Hyundai offers partners multiple avenues of cooperation
such as in and out-licensing, co-marketing, co-promotion,
co-development, R&D investment and joint ventures in
order to provide innovative and valuable drugs to patients.
We work with partners to build mutually beneficial alliances,
where parties involved realize and often exceed strategic
goals. Our strong relationships with domestic and
international partners increase access to new markets.
Hyundai Pharm welcomes collaborative opportunities to
potential partners around the world to bring the best
treatments to the domestic market. We have keen interests
in various discovery research technologies and original drug
development concepts and approaches, to improve the
efficiency of research and development of new drugs.